biguanides has been researched along with Lipodystrophy in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Lipodystrophy: A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeyda, J | 1 |
| Baker, H | 1 |
| Delacrétaz, J | 1 |
2 reviews available for biguanides and Lipodystrophy
| Article | Year |
|---|---|
Drug reactions. X. Adverse cutaneous reactions to hypoglycaemic agents.
Topics: Antigens; Biguanides; Desensitization, Immunologic; Drug Eruptions; Drug Hypersensitivity; Erythema | 1970 |
[Skin and diabetes].
Topics: Biguanides; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Foot Diseases; Hemochro | 1973 |